Literature DB >> 25341473

Estimated prevalence and incidence of multiple sclerosis in Iran.

Masoud Etemadifar1, Sadegh Izadi, Alireza Nikseresht, Maryam Sharifian, Mohammad Ali Sahraian, Zahra Nasr.   

Abstract

BACKGROUND: Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system and its epidemiology has changed in recent years. Previously, Iran was considered to have a low MS prevalence. In this study, we aimed to update the prevalence and incidence of MS in Iran. PATIENTS AND METHODS: This study was conducted based on the data derived from the new report of Iran's Ministry Of Health and Medical Education (MOHME) regarding the patients who have registered to obtain support for treatment in Iran till the end of 2013.
RESULTS: Among the 42,200 registered patients, 32,477 were female and 9,723 were male (sex ratio: 3.34: 1), and 4,545 were diagnosed in 2013. This resulted in a prevalence of 54.51 and an incidence of 5.87 per 100,000.
CONCLUSION: According to our study results, Iran has a medium-to-high prevalence rate of MS. According to the previous epidemiologic studies from Iran, it seems that the prevalence of MS significantly has increased during recent years. This rate is similar to what is seen in many western countries.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25341473     DOI: 10.1159/000365846

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  26 in total

Review 1.  Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.

Authors:  Zahra Nasr; Masoud Majed; Abdolmohamad Rostami; Mohamad Ali Sahraian; Alireza Minagar; Arman Amini; Jeanine C McGee; Masoud Etemadifar
Journal:  Neurol Sci       Date:  2016-06-28       Impact factor: 3.307

2.  The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.

Authors:  Shima Tavakol; Sahar Shakibapour; Sepideh Arbabi Bidgoli
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

3.  Recurrent isolated optic neuritis: A study on 22 patients.

Authors:  Mahsa Arzani; Mohammad Ali Sahraian; Hamed Rezaei; Abdorreza Naser Moghadasi
Journal:  Iran J Neurol       Date:  2017-07-06

4.  Effects of prolonged fasting on fatigue and quality of life in patients with multiple sclerosis.

Authors:  Masoud Etemadifar; Farnaz Sayahi; Raed Alroughani; Nafiseh Toghianifar; Mojtaba Akbari; Zahra Nasr
Journal:  Neurol Sci       Date:  2016-03-19       Impact factor: 3.307

5.  Does M1 anodal transcranial direct current stimulation affects online and offline motor learning in patients with multiple sclerosis?

Authors:  Nooshin Masoudian; Fatemeh Ehsani; Monireh Nazari; Maryam Zoghi; Shapour Jaberzadeh
Journal:  Neurol Sci       Date:  2020-03-27       Impact factor: 3.307

6.  Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.

Authors:  Mohammad Sarmadi; Hanie Saravani; Omid Azizi; Fereshteh Najafi; Mostafa Hadei; Jalil Momeni; Edris Bazrafshan
Journal:  Neurol Sci       Date:  2021-05-03       Impact factor: 3.307

Review 7.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

8.  Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.

Authors:  Seyed Mohammad Sadegh Hosseini; Ali Asgari; Mehdi Rassafiani; Farzaneh Yazdani; Mehrdokht Mazdeh
Journal:  Health Promot Perspect       Date:  2016-03-31

9.  Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.

Authors:  Zahra Salehi; Rozita Doosti; Masoumeh Beheshti; Ehsan Janzamin; Mohammad Ali Sahraian; Maryam Izad
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis.

Authors:  Hormoz Sanaeinasab; Mohsen Saffari; Mahrokh Hashempour; Ali-Akbar Karimi Zarchi; Waleed A Alghamdi; Harold G Koenig
Journal:  Brain Behav       Date:  2017-09-21       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.